BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 26215312)

  • 1. The 1-h oral glucose tolerance test glucose and insulin values are associated with markers of clinical deterioration in cystic fibrosis.
    Coriati A; Ziai S; Lavoie A; Berthiaume Y; Rabasa-Lhoret R
    Acta Diabetol; 2016 Jun; 53(3):359-66. PubMed ID: 26215312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peak glucose during an oral glucose tolerance test is associated with future diabetes risk in adults with cystic fibrosis.
    Bonhoure A; Potter KJ; Colomba J; Boudreau V; Bergeron C; Desjardins K; Carricart M; Tremblay F; Lavoie A; Rabasa-Lhoret R
    Diabetologia; 2021 Jun; 64(6):1332-1341. PubMed ID: 33693987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between exercise capacity and glucose tolerance in cystic fibrosis.
    Foster K; Huang G; Zhang N; Crisalli J; Chini B; Amin R; Elder D
    Pediatr Pulmonol; 2018 Feb; 53(2):154-161. PubMed ID: 29115018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early assessment of glucose abnormalities during continuous glucose monitoring associated with lung function impairment in cystic fibrosis patients.
    Leclercq A; Gauthier B; Rosner V; Weiss L; Moreau F; Constantinescu AA; Kessler R; Kessler L
    J Cyst Fibros; 2014 Jul; 13(4):478-84. PubMed ID: 24359972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Normal adiponectin levels despite abnormal glucose tolerance (or diabetes) and inflammation in adult patients with cystic fibrosis.
    Hammana I; Malet A; Costa M; Brochiero E; Berthiaume Y; Potvin S; Chiasson JL; Coderre L; Rabasa-Lhoret R
    Diabetes Metab; 2007 Jun; 33(3):213-9. PubMed ID: 17418606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cystic fibrosis-related diabetes: the role of peripheral insulin resistance and beta-cell dysfunction.
    Yung B; Noormohamed FH; Kemp M; Hooper J; Lant AF; Hodson ME
    Diabet Med; 2002 Mar; 19(3):221-6. PubMed ID: 11963922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MARKEDLY DELAYED INSULIN SECRETION AND A HIGH RATE OF UNDETECTED OVERT DIABETES CHARACTERIZE GLUCOSE METABOLISM IN ADULT PATIENTS WITH CYSTIC FIBROSIS AFTER LUNG TRANSPLANTATION.
    Winhofer Y; Wolf P; Fellinger P; Tura A; Hillebrand P; Staufer K; Trauner M; Jaksch P; Muraközy G; Kautzky-Willer A; Pacini G; Krebs M; Luger A; Kazemi-Shirazi L
    Endocr Pract; 2019 Mar; 25(3):254-262. PubMed ID: 30913015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms of glucose intolerance in cystic fibrosis.
    Mohan K; Miller H; Dyce P; Grainger R; Hughes R; Vora J; Ledson M; Walshaw M
    Diabet Med; 2009 Jun; 26(6):582-8. PubMed ID: 19538232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Value of continuous glucose monitoring in screening for diabetes in cystic fibrosis].
    Khammar A; Stremler N; Dubus JC; Gross G; Sarles J; Reynaud R
    Arch Pediatr; 2009 Dec; 16(12):1540-6. PubMed ID: 19854630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peak OGTT glucose is associated with lower lung function in young children with cystic fibrosis.
    Prentice BJ; Chelliah A; Ooi CY; Hameed S; Verge CF; Plush L; Widger J
    J Cyst Fibros; 2020 Mar; 19(2):305-309. PubMed ID: 31126898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucose intolerance in cystic fibrosis as a determinant of pulmonary function and clinical status.
    Lavie M; Fisher D; Vilozni D; Forschmidt R; Sarouk I; Kanety H; Hemi R; Efrati O; Modan-Moses D
    Diabetes Res Clin Pract; 2015 Dec; 110(3):276-84. PubMed ID: 26508676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dichotomy between postprandial glucose and lipid profiles in adults with cystic fibrosis: a pilot study.
    Hammana I; Coderre L; Potvin S; Costa M; Berthiaume Y; Lavoie A; Chiasson JL; Levy E; Rabasa-Lhoret R
    J Cyst Fibros; 2009 Mar; 8(2):128-34. PubMed ID: 19083274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of patients with cystic fibrosis presenting an indeterminate glucose tolerance (INDET).
    Coriati A; Ziai S; Azar M; Berthiaume Y; Rabasa-Lhoret R
    J Cyst Fibros; 2016 Jan; 15(1):127-32. PubMed ID: 25818059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natural history of glucose intolerance in patients with cystic fibrosis: ten-year prospective observation program.
    Sterescu AE; Rhodes B; Jackson R; Dupuis A; Hanna A; Wilson DC; Tullis E; Pencharz PB
    J Pediatr; 2010 Apr; 156(4):613-7. PubMed ID: 19962154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucose >200 mg/dL during Continuous Glucose Monitoring Identifies Adult Patients at Risk for Development of Cystic Fibrosis Related Diabetes.
    Taylor-Cousar JL; Janssen JS; Wilson A; Clair CG; Pickard KM; Jones MC; Brayshaw SJ; Chacon CS; Barboa CM; Sontag MK; Accurso FJ; Nichols DP; Saavedra MT; Nick JA
    J Diabetes Res; 2016; 2016():1527932. PubMed ID: 27999822
    [No Abstract]   [Full Text] [Related]  

  • 16. Insulin-secretion abnormalities and clinical deterioration related to impaired glucose tolerance in cystic fibrosis.
    Tofé S; Moreno JC; Máiz L; Alonso M; Escobar H; Barrio R
    Eur J Endocrinol; 2005 Feb; 152(2):241-7. PubMed ID: 15745932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypoglycemia in cystic fibrosis during an extended oral glucose tolerance test.
    Armaghanian N; Hetherington J; Parameswaran V; Chua EL; Markovic TP; Brand-Miller J; Steinbeck K
    Pediatr Pulmonol; 2020 Dec; 55(12):3391-3399. PubMed ID: 32955169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnosis of cystic fibrosis-related glucose abnormalities: Can we shorten the standard oral glucose tolerance test?
    Coriati A; Elisha B; Virassamynaik S; Phaneuf M; Ziai S; Gauthier MS; Rabasa-Lhoret R
    Appl Physiol Nutr Metab; 2013 Dec; 38(12):1254-9. PubMed ID: 24195626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The association between leptin and insulin levels in adults with cystic fibrosis.
    Ziai S; Belson L; Malet A; Tardif A; Berthiaume Y; Coderre L; Rabasa-Lhoret R
    Diabetes Metab; 2012 Feb; 38(1):34-9. PubMed ID: 21925915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral glucose tolerance test and continuous glucose monitoring to assess diabetes development in cystic fibrosis patients.
    Clemente León M; Bilbao Gassó L; Moreno-Galdó A; Campos Martorrell A; Gartner Tizzano S; Yeste Fernández D; Carrascosa Lezcano A
    Endocrinol Diabetes Nutr (Engl Ed); 2018 Jan; 65(1):45-51. PubMed ID: 29137964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.